Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001691630 | SCV001913445 | benign | not provided | 2020-08-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002073251 | SCV002406845 | benign | Townes syndrome | 2023-03-30 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002496012 | SCV002799266 | likely benign | Townes-Brocks syndrome 1 | 2021-12-04 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001691630 | SCV004139349 | likely benign | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | SALL1: BP4, BS1 |
Prevention |
RCV003976010 | SCV004787587 | likely benign | SALL1-related disorder | 2022-09-26 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |